Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modulation of the malignant phenotype with the urokinase-type plasminogen activator and the type I plasminogen activator inhibitor.

Cell differentiation and development : the official journal of the International Society of Developmental Biologists - 2 Dec 1990

Sordat B, Reiter L, Cajot J F

Abstract excerpt

Gene transfer techniques were utilized to evaluate the role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in enhancing or preventing the expression of the invasive malignant phenotype, respectively. Mouse L-cell transfectants expressing human uPA or human PAI-1 as well as mouse B16 transfectants expressing mouse uPA or human PAI-1 were generated. These...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colonic Neoplasms
Share to Heat-Shock Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hot Temperature

Share to Lung Neoplasms

Share to Mice, Inbred C57BL

Share to Neoplasm Transplantation

Share to Phenotype

Source

Identifiers

PMID: 2129155
DOI: 10.1016/0922-3371(90)90040-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modulation of the malignant phenotype with the urokinase-type plasminogen activator and the type I plasminogen activator inhibitor.PMID 2129155Read ↗

Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasisSemantic proximity Read ↗

Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.Semantic proximity Read ↗

Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.Semantic proximity Read ↗

Cancer invasion and metastasis: changing viewsSemantic proximity Read ↗

Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.Semantic proximity Read ↗

Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.Semantic proximity Read ↗

Decreased expression of intercellular adhesion molecule-1 (ICAM-1) and urokinase-type plasminogen activator receptor (uPAR) is associated with tumor cell spreading in vivo.Semantic proximity Read ↗

The urokinase-type plasminogen activator system in cancer metastasis: A reviewSemantic proximity Read ↗

Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.Semantic proximity Read ↗

High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice.Semantic proximity Read ↗

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.Semantic proximity Read ↗

The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.